ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Case Report



Tardive Oculogyric Crisis Due to Aripiprazole Treatment in an Adolescent Patient Diagnosed with Bipolar Disorder

Tugce Canol, Sermin Yalin Sapmaz, Aylin Deniz Uzun, Hasan Kandemir.



Abstract
Download PDF Post

Antipsychotics usage in children and adolescents is becoming widespread. One of the extrapyramidal side effects associated with long-term antipsychotic drug use follow-up is an oculogyric crisis (OGC). OGC is defined as a dystonic reaction commonly observed after typical antipsychotic drug administration. However, there are rare cases which report OGC after atypical antipsychotic use. In this report, we present an adolescent with bipolar disorder who developed OGC after 2 years of aripiprazole and quetiapine use. To best of our knowledge, this case report has been the first case to present the clinical presentation of tardive OGC due to aripiprazole treatment in an adolescent patient. It is important to note that OGC might be observed in the acute phase and it might be as a result of chronic use detected during a clinical follow-up. Safety, tolerability and efficiency of aripiprazole in pediatric populations should be further analyzed in the future studies.

Key words: oculogyric crises, tardive, adolescent, aripiprazole, child, bipolar, psychiatry







Bibliomed Article Statistics

9
5
R
E
A
D
S

1

2
D
O
W
N
L
O
A
D
S
0506
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.